FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

713395006: Brentuximab vedotin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3289141012 Brentuximab vedotin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3289150014 Brentuximab vedotin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
54771000195110 brentuximab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
366591000195118 brentuximab vedotin it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
795571000172118 brentuximab védotine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
69151000195110 Brentuximab vedotin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
889331000195115 Brentuximab Vedotin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brentuximab vedotin (substance) Is a Peptide false Inferred relationship Some
Brentuximab vedotin (substance) Is a Monoclonal antibody true Inferred relationship Some
Brentuximab vedotin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Microtubule inhibitor (disposition) true Inferred relationship Some
Brentuximab vedotin (substance) Is a Microtubule inhibitor true Inferred relationship Some
Brentuximab vedotin (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing brentuximab vedotin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brentuximab vedotin (substance) Inferred relationship Some 1
Brentuximab vedotin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brentuximab vedotin (substance) Inferred relationship Some 1
Brentuximab vedotin-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brentuximab vedotin (substance) Inferred relationship Some 1
Brentuximab vedotin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brentuximab vedotin (substance) Inferred relationship Some 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Brentuximab vedotin (substance) Inferred relationship Some 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Brentuximab vedotin (substance) Inferred relationship Some 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Brentuximab vedotin (substance) Inferred relationship Some 1
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Brentuximab vedotin (substance) Inferred relationship Some 1
Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Brentuximab vedotin (substance) Inferred relationship Some 1
Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Brentuximab vedotin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start